Translating epigenetic modulation of oncogenic pathways into first-in-class small molecule therapeutics.
Location: United States, Massachusetts, Cambridge
Employees: 11-50
Total raised: $30M
Founded date: 2021
Investors 2
| Date | Name | Website |
| 10.12.2021 | Atlas Vent... | atlasventu... |
| 28.05.2022 | Eight Road... | eightroads... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 09.12.2021 | Series A | $30M | Eight Road... |
Mentions in press and media 4
| Date | Title | Description | Source |
| 29.06.2023 | K36 Therapeutics raises $70M in Series B to fund multiple my... | - | fprimecapi... |
| 28.06.2023 | K36 Therapeutics Announces $70 Million Series B Financing to... | - | fprimecapi... |
| 09.12.2021 | K36 Therapeutics Launches with $30 Million Series A Financin... | CAMBRIDGE, Mass., Dec. 9, 2021 /PRNewswire/ -- K36 Therapeutics, Inc. ("K36"), a privately... | marketscre... |
| - | K36 Therapeutics | “Home | K36tx” | fastfounde... |